2Margaritora S,Cesario A,Gusumano G,et al.Is pulmonary function damaged by neoadjuvant lung cancer therapy A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery[J].The Journal of Thoracic and Cardiovascular Surgery,2010,139(6):1457.
3Takeda S,Funakoshi Y,Kadota Y,et al.Fall in diffusing capacity associated with induction therapy for lung cancer:a predictor of postoperative complication[J].Ann Thorac Surg,2006,82:232.
4Baser S,Shannon VR,Eapen GA,et al.Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status[J].Chest,2006,130:1784.
6Pinson P,Klastersky J.The value of lung function measurements for the assessment of chemotherapy in lung cancer patients[J].Lung Cancer,1998,19:179.
7Nowak A K,Byrne M J,Williamson R,et al.Amulticentre phase II study of cisplatin and gemcitabine for malignant mesothelioma[J].Br J Cancer,2002,87:491.
8Treat J,Belani C,Edelman M,et al.A randomized phase III trial of gemcitabine(G)in combination with carboplatin(C)or paclitaxel(P)versus paclitaxel plus carboplatin in advanced(stage IIIB,IV)non-small cell lung cancer(NSCLC):update of the Alpha Oncology Trial(AI-99002L)[J].Proc Am Soc Clin Oncol,2005,23:7025.
9Dimopoulou I,Efstathiou E,Samakovli A,et al.A prospective study on lung toxicity in patients treated with Gemcitabine and Carboplatin:clinical radiological and functional assessment[J].Ann Oncol,2004,15:1250.
10Kudrik F J,Rivera M P,Molina P L,et al.Hypersensitivity pneuonitis in advanced non-small cell lung cancer patients receiving gemcitabine and paclitaxel:report of two cases and a review of the literature[J].Clin Lung Cancer,2002,4:52.
二级参考文献30
1[1]Pavlakis N,Bell DR,Millward MJ,et al.Fatal pulmonary toxicity resulting from treatment with gemcitabine[J].Cancer,1997,80(2):286.
2[2]Gupta N,Ahmed I,Steinberg H,et al.Gemcitabine-induced pulmonary toxicity:case report and review of the literature[J].Am J Clin Oncol, 2002,25(1): 96.
5[5]Pulkkanen K,Kataja V,Johansson R. Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report[J].J Chemother, 2003,15(3): 287.
6[6]Roychowdhury DF,Cassidy CA,Peterson P,et al.A report on serious pulmonary toxicity associated with gemcitabine-based therapy[J].Invest New Drugs, 2002,20(3): 311.
7[7]Joerger M,Gunz A,Speich R,et al.Gemcitabine -related pulmonary toxicity[J].Swiss Med Wkly,2002,132(1-2):17.
4Cellerino R,Tummarello D,Guidi F,et al.A randomized trial of alternating chemotherapy versus best supportive care inadvanced non-small-cell lung cancer[J].J Clin Oncol,2011,9:1453-1461.
5Mitchell PL,Broad A,Rosenthal MA,et al.Randomized phase 2sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer[J].Asia Pac J Clin Oncol,2011,7(4):376-384.
6Agrawal A,Purandare N,Shah S,et al.Response assessment in metronomic chemotherapy:RECIST or PERCIST?[J].Indian J Nucl Med,2014,29:74-80.
7Alsina E, R.uiz-Tovar J, Alpera MR., et al. Incidence of deep vein thrombosis and thrombosis of the portal-mesenteric axis after laparoscopic sleeve gastrectomy[ J ]. J Laparoendosc Adv Surg Tech A, 2014, 24 (9) : 601-615.
